Cytomegalovirus disease prophylaxis in renal transplantation by high dose oral acyclovir: efficacy and limits. 1998

E Bertoni, and A Rosati, and M Zanazzi, and L Moscarelli, and L Di Maria, and R Piperno, and A Orsi, and F Parri, and G Dedola, and M Salvadori
Dept of Renal Transplantation, Careggi University Hospital, Florence, Italy.

UI MeSH Term Description Entries
D008297 Male Males
D011183 Postoperative Complications Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery. Complication, Postoperative,Complications, Postoperative,Postoperative Complication
D003586 Cytomegalovirus Infections Infection with CYTOMEGALOVIRUS, characterized by enlarged cells bearing intranuclear inclusions. Infection may be in almost any organ, but the salivary glands are the most common site in children, as are the lungs in adults. CMV Inclusion,CMV Inclusions,Congenital CMV Infection,Congenital Cytomegalovirus Infection,Cytomegalic Inclusion Disease,Cytomegalovirus Colitis,Cytomegalovirus Inclusion,Cytomegalovirus Inclusion Disease,Cytomegalovirus Inclusions,Inclusion Disease,Perinatal CMV Infection,Perinatal Cytomegalovirus Infection,Renal Tubular Cytomegalovirus Inclusion,Renal Tubular Cytomegalovirus Inclusions,Salivary Gland Virus Disease,Severe Cytomegalovirus Infection,Severe Cytomegalovirus Infections,Infections, Cytomegalovirus,CMV Infection, Congenital,CMV Infection, Perinatal,Colitis, Cytomegalovirus,Congenital CMV Infections,Congenital Cytomegalovirus Infections,Cytomegalic Inclusion Diseases,Cytomegalovirus Colitides,Cytomegalovirus Inclusion Diseases,Cytomegalovirus Infection,Cytomegalovirus Infection, Congenital,Cytomegalovirus Infection, Perinatal,Cytomegalovirus Infection, Severe,Cytomegalovirus Infections, Severe,Disease, Cytomegalic Inclusion,Disease, Cytomegalovirus Inclusion,Diseases, Cytomegalovirus Inclusion,Inclusion Disease, Cytomegalic,Inclusion Disease, Cytomegalovirus,Inclusion Diseases,Inclusion Diseases, Cytomegalovirus,Inclusion, CMV,Inclusion, Cytomegalovirus,Infection, Congenital CMV,Infection, Congenital Cytomegalovirus,Infection, Cytomegalovirus,Infection, Perinatal CMV,Infection, Perinatal Cytomegalovirus,Infection, Severe Cytomegalovirus,Perinatal CMV Infections,Perinatal Cytomegalovirus Infections
D005260 Female Females
D006084 Graft Rejection An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient. Transplant Rejection,Rejection, Transplant,Transplantation Rejection,Graft Rejections,Rejection, Graft,Rejection, Transplantation,Rejections, Graft,Rejections, Transplant,Rejections, Transplantation,Transplant Rejections,Transplantation Rejections
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000212 Acyclovir A GUANOSINE analog that acts as an antimetabolite. Viruses are especially susceptible. Used especially against herpes. Acycloguanosine,9-((2-Hydroxyethoxy)methyl)guanine,Aci-Sanorania,Acic,Aciclobeta,Aciclostad,Aciclovir,Aciclovir Alonga,Aciclovir-Sanorania,Acifur,Acipen Solutab,Acivir,Activir,Acyclo-V,Acyclovir Sodium,Antiherpes Creme,Avirax,Cicloferon,Clonorax,Cusiviral,Genvir,Herpetad,Herpofug,Herpotern,Herpoviric,Isavir,Laciken,Mapox,Maynar,Milavir,Opthavir,Supraviran,Viclovir,Vipral,Virax-Puren,Virherpes,Virmen,Virolex,Virupos,Virzin,Wellcome-248U,Zoliparin,Zovirax,Zyclir,aciclovir von ct,Aci Sanorania,Aciclovir Sanorania,Acyclo V,Alonga, Aciclovir,Sodium, Acyclovir,Solutab, Acipen,Virax Puren,ViraxPuren,Wellcome 248U,Wellcome248U
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective

Related Publications

E Bertoni, and A Rosati, and M Zanazzi, and L Moscarelli, and L Di Maria, and R Piperno, and A Orsi, and F Parri, and G Dedola, and M Salvadori
May 1991, Antimicrobial agents and chemotherapy,
E Bertoni, and A Rosati, and M Zanazzi, and L Moscarelli, and L Di Maria, and R Piperno, and A Orsi, and F Parri, and G Dedola, and M Salvadori
October 1996, Transplantation proceedings,
E Bertoni, and A Rosati, and M Zanazzi, and L Moscarelli, and L Di Maria, and R Piperno, and A Orsi, and F Parri, and G Dedola, and M Salvadori
February 1993, Transplantation,
E Bertoni, and A Rosati, and M Zanazzi, and L Moscarelli, and L Di Maria, and R Piperno, and A Orsi, and F Parri, and G Dedola, and M Salvadori
February 1996, Journal of the American Society of Nephrology : JASN,
E Bertoni, and A Rosati, and M Zanazzi, and L Moscarelli, and L Di Maria, and R Piperno, and A Orsi, and F Parri, and G Dedola, and M Salvadori
August 1988, Clinical pharmacology and therapeutics,
E Bertoni, and A Rosati, and M Zanazzi, and L Moscarelli, and L Di Maria, and R Piperno, and A Orsi, and F Parri, and G Dedola, and M Salvadori
June 1999, Transplant infectious disease : an official journal of the Transplantation Society,
E Bertoni, and A Rosati, and M Zanazzi, and L Moscarelli, and L Di Maria, and R Piperno, and A Orsi, and F Parri, and G Dedola, and M Salvadori
December 1993, The Annals of thoracic surgery,
E Bertoni, and A Rosati, and M Zanazzi, and L Moscarelli, and L Di Maria, and R Piperno, and A Orsi, and F Parri, and G Dedola, and M Salvadori
January 2018, The Annals of pharmacotherapy,
E Bertoni, and A Rosati, and M Zanazzi, and L Moscarelli, and L Di Maria, and R Piperno, and A Orsi, and F Parri, and G Dedola, and M Salvadori
December 1996, Kidney international. Supplement,
E Bertoni, and A Rosati, and M Zanazzi, and L Moscarelli, and L Di Maria, and R Piperno, and A Orsi, and F Parri, and G Dedola, and M Salvadori
October 1995, The Journal of infectious diseases,
Copied contents to your clipboard!